MedPath

Contrast Enhanced Ultrasound imaging to support prostate cancer brachytherapy treatment and follow up after treatment

Conditions
prostate cancer
prostate carcinoma
10038588
Registration Number
NL-OMON30917
Lead Sponsor
Academisch Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
10
Inclusion Criteria

Biopsy proven prostate cancer, treatment with brachytherapy

Exclusion Criteria

severe cardiac problems, severe hypertension

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Oncological outcomes of adjusted radiation dose with prostate brachytherapy<br /><br>based on perfusion imaging outcomes. </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>What happens with prostate blood perfusion after treatmetn with prostate<br /><br>brachytherapy?</p><br>
© Copyright 2025. All Rights Reserved by MedPath